The entero-insular axis and adipose tissue-related factors in the prediction of weight gain in humans

被引:11
作者
Hivert, M-F [1 ]
Langlois, M-F [1 ]
Carpentier, A. C. [1 ]
机构
[1] Univ Sherbrooke, CHU Sherbrooke, Fac Med & Sci Sante, Dept Med,Div Endocrinol, Sherbrooke, PQ J1H 5N4, Canada
基金
加拿大健康研究院;
关键词
adipokines; entero-insular axis; inflammatory markers; insulin; weight gain;
D O I
10.1038/sj.ijo.0803500
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity has now reached epidemic proportions. Epidemiological studies in the past decades have shown that adults gain weight and adiposity from the early twenties until their sixties. In the paediatric population, growing numbers of children and adolescents put on unhealthy weight. Many environmental, socio-economical and biological determinants that predispose to weight gain have been identified thus far. The aim of the present review is to summarize the current knowledge on the role of the circulating levels of adipokines and other entero-insular hormones and biological markers of obesity to predict weight gain in humans. The review focuses on relationship between hormonal and biochemical markers (insulin, insulin-like growth factors, gastrointestinal hormones, leptin, adiponectin, resistin, inflammatory proteins and cytokines) and weight gain in prospective studies. The complex relationships displayed by these hormonal factors with future weight gain in humans are critically reviewed and integrative models are proposed. Overall, most of the studies reported to date made adjustments for baseline body mass index but failed to consider dietary intake and physical activity as confounding factors. Outstanding questions are raised and new directions for future prospective studies are proposed in order to improve our understanding of the role of biological determinants of energy balance and development of obesity in humans.
引用
收藏
页码:731 / 742
页数:12
相关论文
共 77 条
[41]   Familiar predisposition for obesity may modify the predictive value of serum leptin concentrations for long-term weight change in obese women [J].
Lindroos, AK ;
Lissner, L ;
Carlsson, B ;
Carlsson, LMS ;
Torgerson, J ;
Karlsson, C ;
Stenlöf, K ;
Sjöström, L .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 67 (06) :1119-1123
[42]   Birth weight, adulthood BMI, and subsequent weight gain in relation to leptin levels in Swedish women [J].
Lissner, L ;
Karlsson, C ;
Lindroos, AK ;
Sjöström, L ;
Carlsson, B ;
Carlsson, L ;
Bengtsson, C .
OBESITY RESEARCH, 1999, 7 (02) :150-154
[43]   Insulin resistance and the persistence of obesity from childhood into adulthood [J].
Maffeis, C ;
Moghetti, P ;
Grezzani, A ;
Clementi, M ;
Gaudino, R ;
Tatò, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :71-76
[44]  
Mars M, 2005, AM J CLIN NUTR, V81, P570
[45]   Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation [J].
Masuo, K ;
Kawaguchi, H ;
Mikami, H ;
Ogihara, T ;
Tuck, ML .
HYPERTENSION, 2003, 42 (04) :474-480
[46]   Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects [J].
Näslund, E ;
King, N ;
Mansten, S ;
Adner, N ;
Holst, JJ ;
Gutniak, M ;
Hellström, PM .
BRITISH JOURNAL OF NUTRITION, 2004, 91 (03) :439-446
[47]   The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications [J].
Nishida, C ;
Uauy, R ;
Kumanyika, S ;
Shetty, P .
PUBLIC HEALTH NUTRITION, 2004, 7 (1A) :245-250
[48]   Molecules in focus - Insulin-like growth factor II (IGF-II) [J].
O'Dell, SD ;
Day, INM .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1998, 30 (07) :767-771
[49]   Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children [J].
Odeleye, OE ;
deCourten, M ;
Pettitt, DJ ;
Ravussin, E .
DIABETES, 1997, 46 (08) :1341-1345
[50]   Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate [J].
Ong, K ;
Kratzsch, J ;
Kiess, W ;
Dunger, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :1041-1044